» Articles » PMID: 15561479

Smoking, Nicotine Dependence and Psychiatric Comorbidity--a Population-based Study Including Smoking Cessation After Three Years

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2004 Nov 25
PMID 15561479
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence suggests that nicotine-dependent smokers are at increased risk for psychiatric comorbidity but general population data that included the number of nicotine dependence and withdrawal symptoms according to DSM-IV, the Fagerstrom Test for Nicotine Dependence (FTND), somatoform disorders and the number of psychiatric diagnoses are rare. The goal of the present study was to analyse relationships of smoking and nicotine dependence with psychiatric disease and whether psychiatric disease predicts the sustaining of smoking after three years.

Methods: Cohort study with a random adult population sample in a northern German region (N = 4075) including a baseline measurement of ever daily smokers aged 18-64 (n = 2458), a first follow-up of the current smokers at baseline (n = 1552) after 30 months and a second follow-up after 36 months. Measures included DSM-IV diagnoses by the Composite International Diagnostic Interview, FTND, smoking cessation by interview.

Results: Current daily smokers showed higher odds of a substance use disorder other than nicotine dependence compared with never smokers (odds ratio, OR, 4.6; confidence interval, CI, 2.9-7.2), affective (OR 1.8; CI 1.4-2.5), anxiety (OR 1.6; CI 1.2-2.0) or somatoform disorder (OR 1.4; CI 1.0-1.8). DSM-IV nicotine dependence and the FTND were positively related with the number of psychiatric diagnoses. Psychiatric comorbidity did not predict the maintenance of smoking or quitting.

Conclusions: Findings of increased rates of mental disorders among smokers and nicotine-dependent smokers in the adult general population are supported by this study. The number of nicotine dependence and withdrawal symptoms are related to mental disorders. In addition, somatoform disorders show relationships with smoking similar to relationships with depressive or anxiety disorders. The intention to stop smoking should be proactively supported among these comorbid patients.

Citing Articles

Suicide mortality following the implementation of tobacco packaging and pricing policies in Korea: an interrupted time-series analysis.

Jin T, Seo J, Ye S, Lee S, Park E, Oh J BMC Med. 2024; 22(1):180.

PMID: 38679738 PMC: 11057188. DOI: 10.1186/s12916-024-03372-5.


Evaluating the indirect roles of anxiety and depressive symptoms in the relations between negative emotional reactivity to racial/ethnic stress and cigarette smoking among Hispanic adults who smoke.

Zvolensky M, Shepherd J, Argueta S, Bizier A, Clausen B, Buckner J Exp Clin Psychopharmacol. 2024; 32(6):706-716.

PMID: 38451733 PMC: 11866842. DOI: 10.1037/pha0000708.


Real-Life Effectiveness of Smoking Cessation Delivery Modes: A Comparison Against Telephone Counseling and the Role of Individual Characteristics and Health Conditions in Quit Success.

Poole N, Candel M, Willemsen M, van den Brand F Nicotine Tob Res. 2023; 26(4):452-460.

PMID: 37930890 PMC: 10959160. DOI: 10.1093/ntr/ntad195.


Joint effects of depressive status and body mass index on the risk of incident hypertension in aging population: evidence from a nationwide population-based cohort study.

Luo Q, Bao K, Gao W, Xiang Y, Li M, Zhang Y BMC Psychiatry. 2023; 23(1):608.

PMID: 37598204 PMC: 10439533. DOI: 10.1186/s12888-023-05105-z.


Associations between smoking and vaping prevalence, product use characteristics, and mental health diagnoses in Great Britain: a population survey.

Taylor E, Brose L, McNeill A, Brown J, Kock L, Robson D BMC Med. 2023; 21(1):211.

PMID: 37316913 PMC: 10268384. DOI: 10.1186/s12916-023-02890-y.